Johnson & Johnson JNJ
-
Abbott: Don't Miss Out On Its High Growth
By Income Hunter : The pharmaceuticals industry is just like the food and beverage industry in terms of sensitivity. This is because it produces products for human consumption, which makes it the main source of income. Abbott Laboratories ( ABT ) is one major beneficiary of this kind of income and
-
At the top of Goldman Sachs' VIP List of 50 stocks most important to hedge funds is Apple (AAPL), followed by [[GOOG]], [[ESRX]], [[MSFT]], [[QCOM]], [[C]], [[GM]], [[PCLN]], [[JPM]] and [[LMCA]]. ...
… by GOOG , ESRX , MSFT , QCOM , C , GM , PCLN , JPM and LMCA . Leading the list of the firm's top 50 short positions is JNJ , XOM , INTC , IBM , AMZN , T , CVX , VZ , DUK and DIS . 1 comment!
-
A Dendreon Options Trade: Hedging ASCO 2012 Data Releases
By Helix Investment Management : Without a doubt, Dendreon ( DNDN ) is one of the most controversial stocks in the market today. It seems that not a day goes by without a fierce debate over Provenge, its efficacy, and its future place in the prostate cancer market. Over the past year, Dendreon has
-
Johnson & Johnson: An Uncommon Opportunity
By Rajiv Tarigopula : Johnson & Johnson ( JNJ ) , one of the world's leaders ..... Trading near $63 today, Johnson & Johnson has a very healthy dividend ..... increased over the last decade. Johnson & Johnson , with a diversified portfolio …
-
Johnson & Johnson Continues To Trade At Unprecedented Value
By Clay King : Johnson & Johnson ( JNJ ) continues to trade at a historical ..... increased dividend payments paid by Johnson & Johnson . This report is based on the ..... disappoint the investing community. Johnson & Johnson is such a company which has …
-
An FDA advisory panel recommends against approval of Johnson & Johnson's ( JNJ ) Xarelto blood thinner to reduce life-threatening blood clots. JNJ already markets the pill to treat irregular heartbeat ...
An FDA advisory panel recommends against approval of Johnson & Johnson 's ( JNJ ) Xarelto blood thinner to reduce life-threatening blood clots. JNJ already markets the pill to treat irregular heartbeat and patients undergoing hip or knee replacement surgery. Post your comment!
-
Johnson & Johnson: Great Investment But Not For A Short-Term Price Rebound
… of articles proclaiming that Johnson & Johnson ( JNJ ) is a buy right now; that ..... went so far as to say that Johnson & Johnson would hit $68 within the next ..... would be perfectly happy with Johnson & Johnson climbing back to its 52-week …
-
US FDA advisers rebuff J & J /Bayer Xarelto heart drug
SILVER SPRING, Md., May 23 (Reuters) - A U.S. advisory panel rebuffed Johnson & Johnson 's blood thinner, meant to reduce the risk of new heart attacks and strokes in people with heart problems.
-
Our Top 40 Favorite Dividend Champions
… capitalization of my greater earnings. Not from fickle Mr. Market behavior. Disclosure: Long MKC, JCI, ITW, SYY, JNJ , PG, PEP, GPC, MCD, ITW, MDT, AFL, MHP, ABT, MO, T, KMB, CLX, XOM, BCR at the time of writing. Disclaimer …